These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21205125)
1. Pharmaceutical interventions for obesity: a public health perspective. Caveney E; Caveney BJ; Somaratne R; Turner JR; Gourgiotis L Diabetes Obes Metab; 2011 Jun; 13(6):490-7. PubMed ID: 21205125 [TBL] [Abstract][Full Text] [Related]
2. Anti-obesity drugs: use, mechanisms and clinical importance. Adam O; Forth W Int J Clin Pharmacol Ther; 2001 Jun; 39(6):232-8. PubMed ID: 11430630 [TBL] [Abstract][Full Text] [Related]
3. Medical strategies for weight loss in the overweight and obese patient. Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871 [TBL] [Abstract][Full Text] [Related]
4. Health economics of weight management: evidence and cost. Kouris-Blazos A; Wahlqvist ML Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129 [TBL] [Abstract][Full Text] [Related]
5. Use and costs of bariatric surgery and prescription weight-loss medications. Encinosa WE; Bernard DM; Steiner CA; Chen CC Health Aff (Millwood); 2005; 24(4):1039-46. PubMed ID: 16012144 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of weight loss interventions in overweight and obese women. Roux L; Kuntz KM; Donaldson C; Goldie SJ Obesity (Silver Spring); 2006 Jun; 14(6):1093-106. PubMed ID: 16861615 [TBL] [Abstract][Full Text] [Related]
7. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Fujioka K Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660 [TBL] [Abstract][Full Text] [Related]
8. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends? Ballantyne CM Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for the obese patient. Dickerson LM; Carek PJ Prim Care; 2009 Jun; 36(2):407-15. PubMed ID: 19501251 [TBL] [Abstract][Full Text] [Related]
10. Medical interventions in adolescent obesity. Khan UI; Collier M Adolesc Med State Art Rev; 2008 Dec; 19(3):406-20, viii. PubMed ID: 19227383 [TBL] [Abstract][Full Text] [Related]
11. The new role of pharmacotherapy for weight reduction in obesity. Fernstrom MH; Fernstrom JD Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983 [TBL] [Abstract][Full Text] [Related]
12. The global impact of noncommunicable diseases: estimates and projections. Manton KG World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of obesity in children and adolescents: current status and perspectives. Catoira N; Nagel M; Di Girolamo G; Gonzalez CD Expert Opin Pharmacother; 2010 Dec; 11(18):2973-83. PubMed ID: 20958104 [TBL] [Abstract][Full Text] [Related]
14. Anti-obesity drugs: status quo and recent advances. Zhu HJ; Jin ZM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):243-7. PubMed ID: 21718603 [TBL] [Abstract][Full Text] [Related]
15. [Weight reduction. Antiobesity drug treatment in type-2 diabetics]. Verspohl EJ Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127 [No Abstract] [Full Text] [Related]
16. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. Scheen AJ; Ernest P Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323 [TBL] [Abstract][Full Text] [Related]
18. An update on the pharmacological treatment of obesity. Schnee DM; Zaiken K; McCloskey WW Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072 [TBL] [Abstract][Full Text] [Related]